Middletown, DE -- (SBWIRE) -- 10/07/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO), ChemoCentryx Inc (NASDAQ:CCXI), Compuware Corporation (NASDAQ:CPWR), Aastrom Biosciences Inc(NASDAQ:ASTM)
AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO) opened the session at $2.04, remained amid the day range of $2.04- $2.23, and closed the session at $2.11. The stock showed a positive performance of +3.43% in previous trading session. The stock gained a volume of 1.90 million shares and the average volume of the stock remained 471,580.00 shares. AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, operates as a cancer therapeutics company. The company engages in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. AVEO Pharmaceuticals, Inc. was incorporated in 2001 and is based in Cambridge, Massachusetts.
Why Should Investors Buy AVEO After The Recent Gain? Just Go Here and Find Out
ChemoCentryx Inc (NASDAQ:CCXI) traded with volume of 1.89 million shares in the prior session and the average volume of the stock remained 753,464.00 shares. The 52 week range of the stock remained $5.28 - $14.96. The stock showed a negative movement of -1.10% and closed its session at $5.41. The market capitalization of the stock remained 231.74 million. ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. Its drug candidates under clinical stage include Vercirnon.
Why Should Investors Buy CCXI After the Recent Fall? Just Go Here and Find Out
Compuware Corporation (NASDAQ:CPWR) exchanged 1.83 million shares and the average volume remained 2.01 million shares. The stock escalated +0.72% and closed the session at $11.13. The beta of the stock remained 1.23 and the EPS of the stock remained -0.09. The shares outstanding of the stock remained 214.65 million. Compuware Corporation provides services, software, and practices for information technology (IT) organizations worldwide. The company?s Application Performance Management segment offers software-as-a-service solutions to test and monitor the performance, availability, and quality of companies Web and mobile applications.
For How Long CPWR will fight for Profitability? Read This Trend Analysis report
Aastrom Biosciences Inc(NASDAQ:ASTM) gained volume of 1.81 million shares, while the average volume remained 1.30 million shares. The stock decreased -2.14% and finished the session Friday at $0.274. The EPS of the stock remained -0.61. The one month of the stock was -2.14% and three month trend remained negative -25.95%. Aastrom Biosciences, Inc., a development stage company, engages in the development of patient-specific, cell products for use in the treatment of severe, chronic ischemic cardiovascular diseases. It is developing ixmyelocel-T, a patient-specific multicellular therapy expanded from a patient's own bone marrow and delivered directly to damaged tissues.
Has ASTM Found The Bottom and Ready To Move Up? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)